The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers...
Keep Reading →
December 20 - Hedge Funds, News - Comments
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge...
Keep Reading →
October 27 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors...
Keep Reading →
September 9 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
July 13 - Hedge Funds, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
June 5 - Hedge Funds, News - Comments
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Keep Reading →
March 27 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Keep Reading →
December 27 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Keep Reading →
December 3 - Hedge Funds, News - Comments
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors...
Keep Reading →
October 25 - Hedge Funds, News - Comments
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined...
Keep Reading →
June 13 - Hedge Funds, News - Comments
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions...
Keep Reading →
April 23 - Hedge Funds, News - Comments
“Market volatility has picked up again over the past few weeks. Headlines highlight risks regarding interest rates, the Fed, China, house prices...
Keep Reading →
December 17 - Hedge Funds, News - Comments
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Keep Reading →
December 13 - Hedge Funds, News - Comments
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion...
Keep Reading →
November 8 - Hedge Funds, News - Comments
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can...
Keep Reading →
November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments
William Leland Edwards‘ Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management. According to our calculations...
Keep Reading →
March 2 - Hedge Funds, News - Comments
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States...
Keep Reading →
December 1 - Hedge Fund Analysis, Hedge Funds, News - Comments
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by...
Keep Reading →
November 24 - Hedge Funds, News - Comments
March Altus Capital Management, headquartered in Greenwich, Connecticut, was founded by Neil Shah in December 2011.This healthcare focused fund follows...
Keep Reading →
April 16 - Hedge Funds, News - Comments
Paul Orlin‘s Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission...
Keep Reading →
March 27 - Hedge Funds, News - Comments
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday’s intraday trading to eventually close at 18% in the green at $72.48. The rise came...
Keep Reading →
March 25 - Hedge Funds, Market Movers, News - Comments
The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain...
Keep Reading →
March 19 - Hedge Funds, News - Comments
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since. The fund invests in small-cap stocks, with...
Keep Reading →
September 9 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower...
Keep Reading →
May 27 - Hedge Funds, News - Comments
One of the funds we track is Joel Greenblatt‘s Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at...
Keep Reading →
November 15 - Hedge Funds, News - Comments
To many of your fellow Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment...
Keep Reading →
September 11 - News - Comments
As much as I think Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)‘ investors are overestimating the near-term potential for the biotech’s obesity...
Keep Reading →
September 3 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge...
Keep Reading →
August 29 - News - Comments
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge...
Keep Reading →
August 28 - News - Comments
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age. Although there are In excess of 8...
Keep Reading →
August 28 - News - Comments
Is Endo Health Solutions Inc (NASDAQ:ENDP) a buy? To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten...
Keep Reading →
August 27 - News - Comments
In today’s marketplace, there are tons of indicators investors can use to track the equity markets. A couple of the most underrated are hedge fund and...
Keep Reading →
August 27 - News - Comments
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there...
Keep Reading →
August 26 - News - Comments
Organovo Holdings Inc (NYSEMKT:ONVO) is a little company that people think could do big things. Foremost among those “things” is the 3-D...
Keep Reading →
August 25 - News - Comments
Imagine a day where there are no waiting lists for liver transplants. Instead, patients can have a perfectly tailored liver bioprinted and placed into...
Keep Reading →
August 21 - News - Comments
Joel Greenblatt‘s hedge fund, Gotham Asset Management, is one of the institutional investors who recently filed their Q2 13F form with the Securities...
Keep Reading →
August 15 - Hedge Funds - Comments
Ever since August 2011, I’ve been calling out one or two companies every month that I was putting my own retirement money behind. Over that time...
Keep Reading →
August 13 - News - Comments
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds’ portfolio at the end of March. TARO investors should pay attention to an increase...
Keep Reading →
July 1 - News - Comments
United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late. If you’d ask most investors...
Keep Reading →
June 3 - News - Comments
The Medicines Company (NASDAQ:MDCO) has experienced an increase in hedge fund sentiment recently. At the moment, there are a multitude of metrics investors...
Keep Reading →
May 31 - News - Comments
Is Pharmacyclics, Inc. (NASDAQ:PCYC) an outstanding investment now? Money managers are taking an optimistic view. The number of long hedge fund bets went...
Keep Reading →
May 31 - News - Comments
Just in case you missed it, the future has arrived. A Michigan toddler is living proof. Doctors used 3-D printing to create an artificial airway splint...
Keep Reading →
May 28 - News - Comments
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens. Unfortunately, the...
Keep Reading →
May 24 - News - Comments
Gilead Sciences, Inc. (NASDAQ:GILD) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have...
Keep Reading →
May 8 - News - Comments
United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late. At the moment, there are a multitude...
Keep Reading →
April 9 - News - Comments
Gotham Asset Management founder, Joel Greenblatt, is said to use a more cerebral approach to picking stocks. As a professor at Columbia Business School...
Keep Reading →
April 2 - News - Comments
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) Index up 25% over the trailing-12-month period, it’s evident that investment dollars are willingly...
Keep Reading →
March 31 - News - Comments
Normally, our weekly look at what’s going on within the health-care sectors involves a mixture of health-care conferences, FDA panel meetings and...
Keep Reading →
March 24 - News - Comments